148 NDCs across 27 manufacturers|116 Generic,32 Brand
Estradiol is the primary human estrogen, prescribed for menopausal symptoms, and in some cases for osteoporosis prevention and gender-affirming therapy. This market is unusually heterogeneous: oral tablets (Estrace equivalents), transdermal patches (Climara, Vivelle-Dot), topical gels, vaginal creams, and the vaginal ring (Estring) all share the same active ingredient but are priced per tablet, per patch, per gram, or per ring. Comparing per-unit NADAC across those forms is not meaningful — compare within a dosage form instead.
▸ More about this market▾ Less
Estradiol is used to treat breast neoplasms, hot flashes, hypogonadism, premature menopause, menorrhagia and primary ovarian insufficiency, per the National Library of Medicine's MED-RT classification. The brand product was first FDA-approved on Sep 10, 1986, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 116 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $392 million on Estradiol across 5.1 million claims for 1.9 million beneficiaries.
Estradiol is available as 148 NDCs from 27 manufacturers (116 generic, 32 brand), with NADAC prices from $0.06 to $551.44 per EA — the most expensive product costs about 8,939× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
148
116G / 32B
Manufacturers
27
competing in market
Price Spread
$0.06 – $551.44
per EA, 126 of 148 NDCs
7d Activity
78↑68↓0 flat
avg +4.3% WoW · of 148 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Estradiol is used to treat breast neoplasms, hot flashes, hypogonadism, premature menopause, menorrhagia and primary ovarian insufficiency, per the National Library of Medicine's MED-RT classification.
When did Estradiol become available as a generic?
FDA approved the first generic Estradiol (ANDA) on Jan 1, 1982. The Orange Book currently lists 116 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Estradiol?
In 2024, Medicare Part D spent $392 million on Estradiol across 5.1 million claims for 1.9 million beneficiaries.
How many Estradiol products are on the market?
The Estradiol drug market contains 148 NDCs from 27 manufacturers — 116 generic and 32 brand products.
What is the price range for Estradiol?
NADAC reference prices for Estradiol range from $0.0617 to $551.4415 per EA — the most expensive product costs about 8,939× the cheapest. 22 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Estradiol cheaper than brand?
The average generic NADAC for Estradiol is $5.3170 per EA, versus $37.5688 for brand-labeled products — brand versions average about 7.1× the generic price.
Which manufacturers make Estradiol?
27 manufacturers list Estradiol in NADAC. Ranked by number of NDCs, the largest are Mylan Pharmaceuticals Inc. (17), Sandoz Inc. (16), Amneal Pharmaceuticals LLC (12), NorthStar Rx LLC (12), ANI Pharmaceuticals, Inc. (11).
How has the price of Estradiol changed recently?
Over the past 7 days, 78 Estradiol NDCs rose and 68 fell, with a market-wide average change of +4.3%.